Skip to content

Clinical trials

Liver Neoplasms trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Neoplasms Country / region: Hong Kong Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20053
20063
20071
20083
20091
20101
20113
20131
20141
20153
20161
20172
20183
20192
20204
20212
20223
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Active, not recruiting6
Terminated5
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The University of Hong Kong6
Bristol-Myers Squibb5
Novartis Pharmaceuticals5
AstraZeneca3
Bayer2
Hoffmann-La Roche2
Imunon2
Light Sciences Oncology2
Abbott1
Arbele Pty Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Neoplasms44
Carcinoma, Hepatocellular31
Neoplasms5
Liver Diseases3
Adenocarcinoma2
Carcinoma2
Colorectal Neoplasms2
Digestive System Diseases2
Digestive System Neoplasms2
Neoplasms by Histologic Type2

Trials

Showing 26 to 44 of 44. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.